For the attention of Community Pharmacies providing the Autumn 2024 Seasonal Influenza Community Pharmacy Vaccine Service (CPVS):

SPPG have issued the following reminder:

The Autumn 2024/25 Seasonal Influenza Programme Finishes Monday 31st March 2025.

  • Vaccination should not occur after this date and the autumn flu vaccination PGD will no longer be valid.
  • Residual stock: Pharmacies should dispose of any residual aQIV and QIVc stock after 31st March in waste bins provided.

If you have any queries about the Community Pharmacy Vaccination Service (CPVS) please contact Greg Miller (greg.miller@hscni.net) or Grainne McMahon (Grainne.McMahon4@hscni.net).

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The third update of concessionary prices were granted today for March 2025:
DrugPack
Size
Concessionary Price
Buprenorphine 8mg sublingual tablets sugar free7£6.39
Calcium and Ergocalciferol tablets28£7.41
Chloramphenicol 1% eye ointment4£3.08
Clomethiazole 192mg capsules60£34.44
Isosorbide mononitrate 10mg tablets56£3.25
Methylphenidate 10mg tablets30£5.49
Ondansetron 8mg tablets10£3.93
Oxybutynin 5mg tablets56£2.90
Ramipril 2.5mg tablets28£1.19
Ursodeoxycholic acid 300mg tablets60£54.22
Verapamil 80mg tablets84£2.20

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
CPNI wishes to make contractors aware of NICPLD correspondence dated 20 March 2025 which provides further information on the joint selection, recruitment and admission process for Foundation Training Year (FTY) 2026/2027.

SUMMARY

Contractors will note:

  • The joint FTY 2026/2027 selection, recruitment and admission process has been developed by a Task and Finish group established by the Department of Health. 
  • The NICPLD correspondence provides an overview of the process, indicative timelines, and includes an information video.
  • The Task and Finish group will hold a live webinar for prospective FTY employers on 8 April 2025, and registration is available here.
  • CPNI notes that community pharmacies will be asked to “opt-in” to the process between 9 – 25 April 2025.
  • CPNI is aware that community pharmacist representatives, including those on the Task and Finish Group, have raised concerns about some aspects of the joint recruitment process, and have highlighted the need to make more information available to prospective participants.
  • As indicated by DoH legal advice, participating community pharmacies will be required to agree to a terms of participation agreement for the FTY programme and joint recruitment process, and as such they may wish to seek their own legal and/or HR advice.
  • NICPLD has indicated that employers can ask questions during the webinar, or can send queries in advance to nicpld-fty@qub.ac.uk.

ACTION

  • Contractors considering involvement in FTY 2026/2027 are advised to review the correspondence and consider attending the webinar on 8 April 2025.
  • As indicated by DoH legal advice, participating employers will be required to agree to a terms of participation agreement for the FTY programme and the joint recruitment process, and as such they may wish to seek their own legal and/or HR advice.

CPNI considers that arrangements being put forward by NICPLD and DoH for FTY 2026/2027 require contractors to give careful consideration to the responsibilities and obligations that will apply to them in their capacity as the employer of FTY trainees in 2026/27. CPNI continues to liaise with NICPLD and DoH(NI) on these matters and we will keep contractors informed accordingly.

Should you have any questions, please do not hesitate to contact the CPNI team or email Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
*** Webinar this evening 7-8pm ***
Dear Contractor
CPNI issued a contractor email on 10 March 2025 regarding a NICPLD pilot to encourage DPP support for Community Pharmacists undertaking the NICPLD Independent Prescriber training course.  The pilot has now launched and information is available here or on the NICPLD facebook page.  An information webinar will be held this evening from 7-8pm.

SUMMARY

  • As outlined in NICPLD’s letter, funding of £1500 is available for up to 50 eligible DPPs who agree to support a community pharmacist to undertake the NICPLD IP training programme, commencing August 2025.
  • DPPs can be medical or non-medical prescribers (such as community pharmacist IPs) and must meet the DPP criteria outlined in the NICPLD letter.
  • Those interested in being a DPP can express their interest here.
  • The deadline for community pharmacists to submit applications for IP training has been extended to 15 April 2025.
  • An information webinar for prospective applicants or DPPs will be held this evening Monday 24th March, 7-8pm with registration available by emailing nicpld-prescribing@qub.ac.uk.

ACTION

  • Contractors are asked to note the information provided in the NICPLD letter and the flyer and share with relevant members of the team, including any community pharmacists considering IP training, and any existing community pharmacist IPs who may consider acting as a DPP under the support scheme.

Queries on the DPP support scheme can be sent to Nicpld-prescribing@qub.ac.uk.  Alternatively, please do not hesitate to contact the CPNI team or email Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Autumn 2024/25 Community Pharmacy Flu Vaccination Programme

REMINDER:

  • The Autumn 2024/25 Flu vaccination programme is coming to an end on Monday 31 March 2025.
  • Providers are requested to not vaccinate eligible cohorts after this date.
  • Please share this information with all relevant staff to allow adequate time for clinic arrangements and stock management.

Collaborative Forum for Community Pharmacy ECHO Network

An ECHO session is being held on Tuesday 01 April 2025 to discuss Public Health Community Pharmacy Services.  Further information can be found here.

Topic: Update on Public Health Community Pharmacy Services covering Living Well, Stop Smoking and Harm Reduction Services (OST, Needle and Syringe Exchange)

Date: Tuesday 1st April 2025

Time: 7.30pm to 9.00pm

Zoom Meeting ID: 222 006 8769 Passcode: 790079

Link: https://echo.zoom.us/j/2220068769?pwd=jIqxNXa2Lbqn5m798LVmI92gDCOLOf.1

Join via Audio only: 020 3695 0088 and follow the instructions

Pharmacy Student Research

CPNI has been contacted by a final year pharmacy student undertaking research on community pharmacist workforce retention.

The student requires input from a range of community pharmacists participants and would be grateful for any support provided.  Further information and contact details for those who wish to be involved are available in the research flyer.

Inquiry into Access to GPs in Northern Ireland

The Public Accounts Committee is currently undertaking an inquiry into Access to General Practice in Northern Ireland.  Members of the public can find out more about the inquiry here – Access to General Practice in Northern Ireland.  An online survey to gather views will remain open until 27 March 2025.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Shortage Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The second update of concessionary prices were granted today for March 2025:
DrugPack SizeConcessionary Price
Acamprosate 333mg gastro-resistant tablets168£21.65
Alendronic acid 70mg tablets4£1.21
Amantadine 100mg capsules56£14.83
Codeine 15mg/5ml linctus200£16.50
Flucloxacillin 500mg capsules28£2.21
Isosorbide mononitrate 40mg tablets56£3.67
Methocarbamol 750mg tablets100£7.64
Pregabalin 100mg capsules84£2.29
Rizatriptan 10mg tablets3£8.10
Travoprost 40micrograms/ml / timolol 5mg/ml eye drops2.5£11.79

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive